Safety and Efficacy of ALLO-316 in Subjects With Advanced or Metastatic Clear Cell Renal Cell Carcinoma

Name: Safety and Efficacy of ALLO-316 in Subjects With Advanced or Metastatic Clear Cell Renal Cell Carcinoma
Published: 2021
License: Public Domain

Allogene Therapeutics · 2021

ClinicalTrials.gov · Datasets · License: Public Domain · 2021

Open Source ↗

cell-therapy

advanced/metastatic clear cell renal cell carcinoma, car t, cell therapy, allogeneic cell therapy, cellular immuno-therapy, allocar t, allo-316, allo-647, ccrcc, clear cell renal cell carcinoma, interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Safety and Efficacy of ALLO-316 in Subjects With Advanced or Metastatic Clear Cell Renal Cell Carcinoma

Related documents